Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Total Debt (2021 - 2025)

Historic Total Debt for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $150000.0.

  • Coeptis Therapeutics Holdings' Total Debt changed 0.0% to $150000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $150000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.2 million for FY2024, which is 69432.27% up from last year.
  • Per Coeptis Therapeutics Holdings' latest filing, its Total Debt stood at $150000.0 for Q3 2025, which was down 0.0% from $150000.0 recorded in Q2 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Total Debt registered a high of $1.6 million during Q4 2021, and its lowest value of $150000.0 during Q4 2022.
  • Moreover, its 5-year median value for Total Debt was $150000.0 (2022), whereas its average is $393593.5.
  • Per our database at Business Quant, Coeptis Therapeutics Holdings' Total Debt tumbled by 9090.91% in 2022 and then surged by 69432.27% in 2024.
  • Quarter analysis of 5 years shows Coeptis Therapeutics Holdings' Total Debt stood at $1.6 million in 2021, then plummeted by 90.91% to $150000.0 in 2022, then changed by 0.0% to $150000.0 in 2023, then surged by 694.32% to $1.2 million in 2024, then tumbled by 87.41% to $150000.0 in 2025.
  • Its last three reported values are $150000.0 in Q3 2025, $150000.0 for Q2 2025, and $785489.0 during Q1 2025.